Mross, Klaus G. : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (59)
Les plus populaires
Liste
- Liste
- Tableau

1

Inhibition des VEGF- Rezeptorsystems mit Tyrosinkinase-Inhibitoren. Angiogenese-Inhibition in der Onkologie

Journal:

Pharmazie in unserer Zeit

Année:

2008

Langue:

german

Fichier:

PDF, 1.26 MB

german, 2008

2

DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study

Klaus Mross, Ulrike Fasol, Annette Frost, Robin Benkelmann, Jan Kuhlmann, Martin Büchert, Clemens Unger, Hubert Blum, Jürgen Hennig, Tsveta P Milenkova, Jean Tessier, Annetta D Krebs, Anderson J Ryan,

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 1.14 MB

english, 2009

3

Uptake of permethrin from impregnated clothing

Rossbach, Bernd, Appel, Klaus E., Mross, Klaus G., Letzel, Stephan

Journal:

Toxicology Letters

Année:

2010

Langue:

english

Fichier:

PDF, 161 KB

english, 2010

4

Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical Experience

Frost, Annette, Gmehling, Daniela, Azemar, Marc, Unger, Clemens, Mross, Klaus

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 320 KB

english, 2006

5

Hyperthermie und neoadjuvante Chemotherapie — eine Option?

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 117 KB

german, 2010

6

Linearized Colorimetric Assay for Cremophor EL: Application to Pharmacokinetics after 1-Hour Paclitaxel Infusions

Eric Brouwer, Jaap Verweij, Bernhard Hauns, Walter J. Loos, Kees Nooter, Klaus Mross, Gerrit Stoter, Alex Sparreboom

Journal:

Analytical Biochemistry

Année:

1998

Langue:

english

Fichier:

PDF, 118 KB

english, 1998

7

Clinical trials with anti-angiogenic agents in hematological malignancies

Michael Medinger, Klaus Mross

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 1.40 MB

english, 2010

8

Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer

Klaus Mross, Annette Frost, Max E Scheulen, Jürgen Krauss, Dirk Strumberg, Beate Schultheiss, Ulrike Fasol, Martin Büchert, Jörn Krätzschmer, Heinz Delesen, Prabhu Rajagopalan, Olaf Christensen

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 178 KB

english, 2011

9

Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study

Klaus Mross, Bernward Niemann, Ulrich Massing, Joachim Drevs, Clemens Unger, Rupinder Bhamra, Christine E. Swenson

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2004

Langue:

english

Fichier:

PDF, 356 KB

english, 2004

10

c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis

Michael Medinger, Manuela Kleinschmidt, Klaus Mross, Barbara Wehmeyer, Clemens Unger, Hans-Eckart Schaefer, Renate Weber, Marc Azemar

Journal:

Pathology & Oncology Research

Année:

2010

Langue:

english

Fichier:

PDF, 281 KB

english, 2010

11

Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients

William Krüger, Cordula Krzizanowski, Michael Holweg, Marcus Stockschläder, Nicolaus Kröger, Roman Jung, Klaus Mross, Walter Jonat, Axel R. Zander

Journal:

Journal of Cancer Research and Clinical Oncology

Année:

1996

Langue:

english

Fichier:

PDF, 920 KB

english, 1996

12

Risk assessment of Bundeswehr (German Federal Armed Forces) permethrin-impregnated battle dress uniforms (BDU)

Klaus E. Appel, Ursula Gundert-Remy, Horst Fischer, Michael Faulde, Klaus G. Mross, Stephan Letzel, Bernd Rossbach

Journal:

International Journal of Hygiene and Environmental Health

Année:

2008

Langue:

english

Fichier:

PDF, 348 KB

english, 2008

13

Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours

Klaus Mross, Joachim Drevs, Marianne Müller, Michael Medinger, Dieter Marmé, Jürgen Hennig, Bruno Morgan, David Lebwohl, Eric Masson, Yu-Yun Ho, Clemens Günther, Dirk Laurent, Clemens Unger

Journal:

European Journal of Cancer

Année:

2005

Langue:

english

Fichier:

PDF, 152 KB

english, 2005

14

Peripheral neuropathy: A persisting challenge in paclitaxel-based regimes

Stephan Mielke, Alex Sparreboom, Klaus Mross

Journal:

European Journal of Cancer

Année:

2006

Langue:

english

Fichier:

PDF, 206 KB

english, 2006

15

Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia

Tristan M. Sissung, Klaus Mross, Seth M. Steinberg, Dirk Behringer, William D. Figg, Alex Sparreboom, Stephan Mielke

Journal:

European Journal of Cancer

Année:

2006

Langue:

english

Fichier:

PDF, 138 KB

english, 2006

16

First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours

Clemens Unger, Wolfgang Berdel, Axel-R Hanauske, Herbert Sindermann, Jürgen Engel, Klaus Mross

Journal:

European Journal of Cancer

Année:

2010

Langue:

english

Fichier:

PDF, 199 KB

english, 2010

17

Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trials

Journal:

Drug Resistance Updates

Année:

2000

Langue:

english

Fichier:

PDF, 862 KB

english, 2000

18

Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarker

Friederike Kanefendt, Andreas Lindauer, Klaus Mross, Uwe Fuhr, Ulrich Jaehde

Journal:

Journal of Pharmaceutical and Biomedical Analysis

Année:

2012

Langue:

english

Fichier:

PDF, 331 KB

english, 2012

19

Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients

Mross, Klaus, Mayer, Ulrich, Langenbuch, Tobias, Hamm, Kirsten, Burk, Konrad, Hossfeld, Dieter

Journal:

European Journal of Cancer and Clinical Oncology

Année:

1990

Langue:

english

Fichier:

PDF, 930 KB

english, 1990

20

Morphometric study of myocardial changes during doxorubicin-induced cardiomyopathy in mice

van der Vijgh, Wim J.F., van Velzen, Dick, van der Poort, Jos S.E., Schlüper, Henny M.M., Mross, Klaus, Feijen, Jan, Pinedo, Herbert M.

Journal:

European Journal of Cancer and Clinical Oncology

Année:

1988

Langue:

english

Fichier:

PDF, 658 KB

english, 1988

21

New anthracycline derivatives: What for?

Journal:

European Journal of Cancer and Clinical Oncology

Année:

1991

Langue:

english

Fichier:

PDF, 477 KB

english, 1991

22

Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis

Klaus Mross,Martin Büchert,Annette Frost,Michael Medinger,Peter Stopfer…

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 539 KB

english, 2014

23

PAC Fixed Dose: Pharmacokinetics of a 1-Hour Paclitaxel Infusion and Comparison to BSA-Normalized Drug Dosing

Mross, Klaus, Holl&auml, nder, Norbert, Frost, Annette, Unger, Clemens, Ziroli, Vittorio, Massing, Ulrich

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 227 KB

english, 2006

24

IR-TrueFISP: A New DCE-MRI Approach in Comparison with 3D-Flash Multi Flip Angle Method

Buechert,, Buechert,, Klaus Mross,

Journal:

Magnetic Resonance Insights

Année:

2012

Langue:

english

Fichier:

PDF, 1.60 MB

english, 2012

25

Phase II Study with 5-Fluorouracil and Ginkgo biloba Extract (GBE 761 ONC) in Patients with Pancreatic Cancer

Hauns, Bernhard, Häring, Brigitte, Köhler, Stephan, Mross, Klaus, Robben-Bathe, Petra, Unger, Clemens

Journal:

Arzneimittelforschung

Année:

2011

Fichier:

PDF, 60 KB

2011

26

Phase II Study with 3rd- or 4th-Line Bendamustine (Flat Dose) Therapy in Patients with Metastatic Breast Cancer

Steinbild, Simone, Frost, Annette, H&auml, ring, Brigitte, Unger, Clemens, Mross, Klaus

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 100 KB

english, 2009

27

Palliative Chemotherapy in Pretreated Patients with Advanced Cancer: Oral Trofosfamide Is Effective in Ovarian Carcinoma

Gunsilius, Eberhard, Gierlich, Thomas, Mross, Klaus, Gastl, Günther, Unger, Clemens

Journal:

Cancer Investigation

Année:

2001

Langue:

english

Fichier:

PDF, 244 KB

english, 2001

28

Inter-relationships of paclitaxel disposition, infusion duration and Cremophor EL kinetics in cancer patients

van Zuylen, Lia, Gianni, Luca, Verweij, Jaap, Mross, Klaus, Brouwer, Eric, Loos, Walter J, Sparreboom, Alex

Journal:

Anti-Cancer Drugs

Année:

2000

Langue:

english

Fichier:

PDF, 131 KB

english, 2000

29

Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR)

Mross, Klaus, Scheulen, Max E., Licht, Thomas, Unger, Clemens, Richly, Heike, Stern, Angelika C., Kutz, Klaus, Camboni, Maria G., Barbieri, Paola, Verdi, Elena, Vincenzi, Beatrice, Bernareggi, Alberto

Journal:

Anti-Cancer Drugs

Année:

2004

Langue:

english

Fichier:

PDF, 158 KB

english, 2004

30

Gemcitabine and interferon-α 2b in solid tumors: a phase I study in patients with advanced or metastatic non-small cell lung, ovarian, pancreatic or renal cancer

Fuxius, Stefan, Mross, Klaus, Mansouri, Kambiz, Unger, Clemens

Journal:

Anti-Cancer Drugs

Année:

2002

Langue:

english

Fichier:

PDF, 96 KB

english, 2002

31

Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h

Mielke, Stephan, Mross, Klaus, Gerds, Thomas A., Schmidt, Anja, W??sch, Ralph, Berger, Dietmar P., Lange, Winand, Behringer, Dirk

Journal:

Anti-Cancer Drugs

Année:

2003

Langue:

english

Fichier:

PDF, 138 KB

english, 2003

32

Sinnvoller Einsatz von Leukozyten-stimulierenden Substanzen

Journal:

Année:

2012

Langue:

german

Fichier:

PDF, 126 KB

german, 2012

33

Nivolumab ist nach platinhaltiger Primärtherapie wirksamer als Docetaxel

Journal:

Année:

2015

Langue:

german

Fichier:

PDF, 186 KB

german, 2015

34

Gibt es einen Favoriten bei den Tubulininhibitoren?

Journal:

Année:

2015

Langue:

german

Fichier:

PDF, 210 KB

german, 2015

35

Wie teuer darf ein potenzieller Überlebensvorteil sein?

Journal:

Année:

2012

Langue:

german

Fichier:

PDF, 176 KB

german, 2012

36

Addition von Ramucirumab zu FOLFIRI in der Zweitlinie

Journal:

Année:

2015

Langue:

german

Fichier:

PDF, 177 KB

german, 2015

37

Die Kombination aus Trifluridin und Tipiracil-hydrochlorid, TAS-102, auf dem Prüfstand

Journal:

Année:

2015

Langue:

german

Fichier:

PDF, 149 KB

german, 2015

38

Welchen Einfluss hat das Malariamedikament Artesunat?

Journal:

Année:

2015

Langue:

german

Fichier:

PDF, 140 KB

german, 2015

39

VEGFR2-Hemmer bei metastasiertem Brustkrebs ohne Zusatznutzen

Journal:

Année:

2015

Langue:

german

Fichier:

PDF, 181 KB

german, 2015

40

Bevacizumab — eine endlose Geschichte

Journal:

Année:

2012

Langue:

german

Fichier:

PDF, 702 KB

german, 2012

41

A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors

Mross, Klaus, Richly, Heike, Frost, Annette, Scharr, Dirk, Nokay, Bahar, Graeser, Ralph, Lee, Chooi, Hilbert, James, Goeldner, Rainer-George, Fietz, Oliver, Scheulen, Max E.

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2016

Langue:

english

Fichier:

PDF, 1.29 MB

english, 2016

42

Metronomic Antiangiogenic Therapy with Capecitabine and Celecoxib in Advanced Tumor Patients – Results of a Phase II Study

Steinbild, Simone, Arends, Jann, Medinger, Michael, Häring, Brigitte, Frost, Annette, Drevs, Joachim, Unger, Clemens, Strecker, Ralph, Hennig, Jürgen, Mross, Klaus

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 138 KB

english, 2007

43

Zulassung ohne große randomisierte Studien?

PD Dr. med. Klaus Mross,Dr. med. Arno Wolff…

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 131 KB

german, 2010

44

Diagnose und Subklassifikation von Leukämien mittels Genexpressionsprofilen

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 184 KB

german, 2010

45

Das Überleben wird marginal verlängert

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 110 KB

german, 2010

46

Entwicklung eines q2w-Applikationsschemas für Cetuximab ist sinnvoll

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 110 KB

german, 2010

47

Wie sinnvoll sind multiple Biomarkeruntersuchungen?

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 104 KB

german, 2010

48

Mediterrane Kost senkt das Krebsrisiko

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 173 KB

german, 2010

49

Brauchen wir den Kardio-Onkologen?

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 95 KB

german, 2010

50

Können Biomarker die Progression voraussagen?

PD Dr. med. Klaus Mross

Journal:

Année:

2010

Langue:

german

Fichier:

PDF, 105 KB

german, 2010